1. Home
  2. IMCC vs BGLC Comparison

IMCC vs BGLC Comparison

Compare IMCC & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IM Cannabis Corp.

IMCC

IM Cannabis Corp.

HOLD

Current Price

$1.42

Market Cap

10.4M

Sector

Health Care

ML Signal

HOLD

Logo BioNexus Gene Lab Corp

BGLC

BioNexus Gene Lab Corp

HOLD

Current Price

$4.09

Market Cap

10.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMCC
BGLC
Founded
1980
2017
Country
Israel
Malaysia
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.4M
10.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IMCC
BGLC
Price
$1.42
$4.09
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
276.1K
204.4K
Earning Date
11-13-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$37,606,703.00
$9,465,006.00
Revenue This Year
$47.12
N/A
Revenue Next Year
$12.83
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.92
2.21
52 Week Low
$0.93
$2.01
52 Week High
$7.12
$15.60

Technical Indicators

Market Signals
Indicator
IMCC
BGLC
Relative Strength Index (RSI) 45.53 34.72
Support Level $1.33 $3.98
Resistance Level $1.59 $4.23
Average True Range (ATR) 0.23 0.15
MACD -0.03 0.01
Stochastic Oscillator 17.33 5.26

Price Performance

Historical Comparison
IMCC
BGLC

About IMCC IM Cannabis Corp.

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.

About BGLC BioNexus Gene Lab Corp

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

Share on Social Networks: